Commercial intelligence gives biotech ventures a competitive edge to beat the odds.
Sit down for a chat to work out what you need, where Auxinia can help, and your timeline and budget. NDA optional.
A low investment and deeper read on where you are. Recommendations for reaching the next value inflection point.
A deep look at the commercial landscape, the opportunity, with the option to bring in KOL feedback on positioning. Bespoke and scoped to your situation.
Flexible retainer to provide landscape monitoring and regular strategy meetings. Plus projects as and when need arises.
Long-term engagements start with in-depth foundational research. That is what makes the intelligence that follows specific to the nuances of your situation.
Cash-flow uncertainty is a common part of the biotech journey. Unlike a salary, retainers can be paused to cover periods of low funding. Ad-hoc projects bring in the expertise as and when you need it.
Many aspects of commercial intelligence can be enhanced by the thoughtful application of AI.
Auxinia treats AI as a highly competent but untrustworthy intern bringing the benefit of experienced human oversight with machine efficiency.
Auxinia works on an anti-slop basis. Every claim is rigorously validated and sense-checked for accuracy and relevance.
“And I wondered, will this compound live in a fridge for 10 years, become an interesting paper… or develop into something that could materially change someone’s life?”
Flora Shimi founded Auxinia to support biotech companies advance their science into life-changing therapeutics.
Commercial intelligence gives biotech ventures a competitive edge to beat the odds.
Book a scoping callSee how we work“And I wondered, will this compound live in a fridge for 10 years, become an interesting paper… or develop into something that could materially change someone’s life?”
Flora Shimi founded Auxinia to support biotech companies advance their science into life-changing therapeutics.
About →